Fate Therapeutics (FATE) Share-based Compensation (2012 - 2026)
Fate Therapeutics (FATE) posted Share-based Compensation of $480,000 for Q4 2015, down 21.6% from $612,000 a year earlier and down 16.4% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Share-based Compensation (2012 - 2026) Analysis & Trends
For FY2015, Fate Therapeutics' Share-based Compensation came in at $2.4 million, down 1.4% from FY2014.
- Annual Share-based Compensation shows a four-year compound annual growth rate of 93.3% (FY2011 to FY2015).
- In prior years, Fate Therapeutics' Share-based Compensation was $2.43 million in FY2014 (+56.6%), $1.55 million in FY2013 (+902.6%), $155,000 in FY2012 (-9.9%) and $172,000 in FY2011.
- The Q4 2015 figure stands as the lowest quarterly Share-based Compensation since Q2 2014.
- On a year-over-year basis, Share-based Compensation increased in four of the last seven quarters, with growth averaging 46.1%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2013, with growth of 685.7%; the weakest was Q3 2014, with a decline of 46.3%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $574,000 (Q3 2015), $738,000 (Q2 2015) and $608,000 (Q1 2015).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Fate Therapeutics | 248.02 Mn | 94.22 Mn | - | 3.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.52 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 7.15 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 9.12 Mn |
| Sep 30, 2024 | 11.77 Mn |
| Jun 30, 2024 | 9.63 Mn |
| Mar 31, 2024 | 10.98 Mn |
| Dec 31, 2023 | 9.48 Mn |
| Sep 30, 2023 | 10.10 Mn |
| Jun 30, 2023 | 12.90 Mn |
| Mar 31, 2023 | 10.98 Mn |
| Dec 31, 2022 | 19.39 Mn |
| Sep 30, 2022 | 19.47 Mn |
| Jun 30, 2022 | 20.54 Mn |
| Mar 31, 2022 | 19.33 Mn |
| Dec 31, 2021 | 14.59 Mn |
| Sep 30, 2021 | 13.54 Mn |
API Access
Fate Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();